Literature DB >> 16724641

The pathogenesis of constipation.

Nigel P Sykes1.   

Abstract

The pathogenesis of the constipation that is commonly experienced by cancer patients, especially those with advanced disease, is the result of multiple influences on the control of intestinal motility and fluid handling. These factors include the direct effects of malignancy on gut structure, paraneoplastic neural impairment, biochemical disturbance, and adverse effects of cancer treatments. In addition, the debility and reduced oral intake associated with cancer also contribute, as, perhaps, might the older age of many cancer patients. A detailed understanding of the mechanisms of constipation, especially in association with illness, is lacking, and most treatments remain nonspecific.

Entities:  

Mesh:

Year:  2006        PMID: 16724641

Source DB:  PubMed          Journal:  J Support Oncol        ISSN: 1544-6794


  6 in total

1.  Cancer constipation: are opioids really the culprit?

Authors:  Mellar P Davis
Journal:  Support Care Cancer       Date:  2008-01-15       Impact factor: 3.603

Review 2.  [Is the pharmacological treatment of constipation in palliative care evidence based? : a systematic literature review].

Authors:  S Bader; M Weber; G Becker
Journal:  Schmerz       Date:  2012-09       Impact factor: 1.107

3.  Self-reported constipation in patients with advanced cancer: a preliminary report.

Authors:  Wadih Rhondali; Linh Nguyen; Lynn Palmer; Duck-Hee Kang; David Hui; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2012-07-25       Impact factor: 3.612

4.  Constipation in cancer patients on morphine.

Authors:  Joanne Droney; Joy Ross; Sophy Gretton; Ken Welsh; Hiroe Sato; Julia Riley
Journal:  Support Care Cancer       Date:  2008-01-16       Impact factor: 3.603

Review 5.  Cancer-related constipation.

Authors:  Jay Thomas
Journal:  Curr Oncol Rep       Date:  2007-07       Impact factor: 5.075

6.  Recent advances in the use of opioids for cancer pain.

Authors:  Joanne Droney; Julia Riley
Journal:  J Pain Res       Date:  2009-09-23       Impact factor: 3.133

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.